Literature DB >> 34854531

Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation.

Jack C Lennon1, Stephen L Aita2, Victor A Del Bene3, Tasha Rhoads4, Zachary J Resch4, Janelle M Eloi2, Keenan A Walker5.   

Abstract

INTRODUCTION: Although dementia prevalence differs by race, it remains unclear whether cognition and neuropsychiatric symptom severity differ between Black and White individuals with dementia.
METHODS: Using National Alzheimer's Coordinating Center (NACC) data, we evaluated dementia prevalence in non-Hispanic Black and White participants and compared their clinicodemographic characteristics. We examined race differences in cognition, neuropsychiatric symptoms, and functional abilities in participants with dementia using multivariable linear and logistic regression models.
RESULTS: We included 5,700 Black and 31,225 White participants across 39 Alzheimer's Disease Research Centers. Of these, 1,528 (27%) Black and 11,267 (36%) White participants had dementia diagnoses. Despite having lower dementia prevalence, risk factors were more prevalent among Black participants. Black participants with dementia showed greater cognitive deficits, neuropsychiatric symptoms/severity, and functional dependence. DISCUSSION: Despite lower dementia prevalence, Black participants with dementia had more dementia risk factors, as well as greater cognitive impairment and neuropsychiatric symptom severity than White participants.
© 2021 the Alzheimer's Association.

Entities:  

Keywords:  African American; cognition; dementia; neuropsychiatric symptoms; racial/ethnic disparities

Mesh:

Year:  2021        PMID: 34854531      PMCID: PMC9160212          DOI: 10.1002/alz.12509

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  50 in total

1.  Cognitive decline and literacy among ethnically diverse elders.

Authors:  Jennifer J Manly; Nicole Schupf; Ming-X Tang; Yaakov Stern
Journal:  J Geriatr Psychiatry Neurol       Date:  2005-12       Impact factor: 2.680

Review 2.  Serotonergic system, cognition, and BPSD in Alzheimer's disease.

Authors:  Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong
Journal:  Neurosci Lett       Date:  2019-04-01       Impact factor: 3.046

3.  Clinical aspects of Alzheimer's disease in black and white patients.

Authors:  R Hargrave; M Stoeklin; M Haan; B Reed
Journal:  J Natl Med Assoc       Date:  1998-02       Impact factor: 1.798

4.  Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates.

Authors:  Somaia Mohamed; Robert Rosenheck; Constantine G Lyketsos; Lon S Schneider
Journal:  Am J Geriatr Psychiatry       Date:  2010-10       Impact factor: 4.105

5.  Challenges and opportunities: recruitment and retention of African Americans for Alzheimer disease research: lessons learned.

Authors:  Edna L Ballard; Lisa P Gwyther; Henry L Edmonds
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

6.  Racial and ethnic disparities in the treatment of dementia among Medicare beneficiaries.

Authors:  Ilene H Zuckerman; Priscilla T Ryder; Linda Simoni-Wastila; Thomas Shaffer; Masayo Sato; Lirong Zhao; Bruce Stuart
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2008-09       Impact factor: 4.077

7.  Literacy and memory decline among ethnically diverse elders.

Authors:  Jennifer J Manly; Pegah Touradji; Ming-Xin Tang; Yaakov Stern
Journal:  J Clin Exp Neuropsychol       Date:  2003-08       Impact factor: 2.475

8.  Are there sensitive time periods for dementia caregivers? The occurrence of behavioral and psychological symptoms in the early stages of dementia.

Authors:  K A Ornstein; J E Gaugler; D P Devanand; N Scarmeas; C W Zhu; Y Stern
Journal:  Int Psychogeriatr       Date:  2013-06-03       Impact factor: 3.878

9.  APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.

Authors:  Lei Yu; Michael W Lutz; Robert S Wilson; Daniel K Burns; Allen D Roses; Ann M Saunders; Jingyun Yang; Chris Gaiteri; Philip L De Jager; Lisa L Barnes; David A Bennett
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

10.  Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS).

Authors:  Sandra Weintraub; Lilah Besser; Hiroko H Dodge; Merilee Teylan; Steven Ferris; Felicia C Goldstein; Bruno Giordani; Joel Kramer; David Loewenstein; Dan Marson; Dan Mungas; David Salmon; Kathleen Welsh-Bohmer; Xiao-Hua Zhou; Steven D Shirk; Alireza Atri; Walter A Kukull; Creighton Phelps; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Jan-Mar       Impact factor: 2.703

View more
  1 in total

1.  Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community-based sample of 70-year-olds.

Authors:  Anna Dittrich; Nicholas J Ashton; Henrik Zetterberg; Kaj Blennow; Joel Simrén; Fiona Geiger; Anna Zettergren; Sara Shams; Alejandra Machado; Eric Westman; Michael Schöll; Ingmar Skoog; Silke Kern
Journal:  Alzheimers Dement (Amst)       Date:  2022-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.